Tetsushi Sadakata

Tetsushi Sadakata

Auto-generated profile, based on publicly available information

Tetsushi Sadakata

Gunma University Graduate School of Medicine

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2007 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
TSTetsushi Sadakata
Tetsushi Sadakata
MWMiwa Washida
Miwa Washida
YIYoshimi Iwayama
Yoshimi Iwayama
SSSatoshi Shoji
Satoshi Shoji
YSYumi Sato
Yumi Sato
TFTeiichi Furuichi
Teiichi Furuichi
Autism, characterized by profound impairment in social interactions and communicative skills, is the most common neurodevelopmental disorder, and its underlying molecular mechanisms remain unknown. Ca2+-dependent activator protein for secretion 2 (CADPS2; also known as CAPS2) mediates the exocytosis of dense-core vesicles, and the human CADPS2 is located within the autism susceptibility locus 1 on chromosome 7q. Here we show that Cadps2-knockout mice not only have impaired brain-derived neurotrophic factor release but also show autistic-like cellular and behavioral phenotypes. Moreover, we found an aberrant alternatively spliced CADPS2 mRNA that lacks exon 3 in some autistic patients. Exon 3 was shown to encode the dynactin 1–binding domain and affect axonal CADPS2 protein distribution. Our results suggest that a disturbance in CADPS2-mediated neurotrophin release contributes to autism susceptibility.

7 March 2007 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
TSTetsushi Sadakata
Tetsushi Sadakata
WKWataru Kakegawa
Wataru Kakegawa
AMAkira Mizoguchi
Akira Mizoguchi
MWMiwa Washida
Miwa Washida
RKRitsuko Katoh-Semba
Ritsuko Katoh-Semba
TFTeiichi Furuichi
Teiichi Furuichi
Ca2+-dependent activator protein for secretion 2 (CAPS2/CADPS2) is a secretory granule-associated protein that is abundant at the parallel fiber terminals of granule cells in the mouse cerebellum and is involved in the release of neurotrophin-3 (NT-3) and brain-derived neurotrophic factor (BDNF), both of which are required for cerebellar development. The human homolog gene on chromosome 7 is located within susceptibility locus 1 of autism, a disease characterized by several cerebellar morphological abnormalities. Here we report thatCAPS2knock-out mice are deficient in the release of NT-3 and BDNF, and they consequently exhibit suppressed phosphorylation of Trk receptors in the cerebellum; these mice exhibit pronounced impairments in cerebellar development and functions, including neuronal survival, differentiation and migration of postmitotic granule cells, dendritogenesis of Purkinje cells, lobulation between lobules VI and VII, structure and vesicular distribution of parallel fiber–Purkinje cell synapses, paired-pulse facilitation at parallel fiber–Purkinje cell synapses, rotarod motor coordination, and eye movement plasticity in optokinetic training. Increased granule cell death of the external granular layer was noted in lobules VI–VII and IX, in which high BDNF and NT-3 levels are specifically localized during cerebellar development. Therefore, the deficiency of CAPS2 indicates that CAPS2-mediated neurotrophin release is indispensable for normal cerebellar development and functions, including neuronal differentiation and survival, morphogenesis, synaptic function, and motor leaning/control. The possible involvement of theCAPS2gene in the cerebellar deficits of autistic patients is discussed.

7 January 2004 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
TSTetsushi Sadakata
Tetsushi Sadakata
AMAkira Mizoguchi
Akira Mizoguchi
YSYumi Sato
Yumi Sato
RKRitsuko Katoh-Semba
Ritsuko Katoh-Semba
Mitsunori FukudaMitsunori Fukuda
Mitsunori Fukuda
TFTeiichi Furuichi
Teiichi Furuichi
Neurotrophins are key modulators of various neuronal functions, including differentiation, survival, and synaptic plasticity, but the molecules that regulate their secretion are poorly understood. We isolated a clone that is predominantly expressed in granule cells of postnatally developing mouse cerebellum, which turned out to be a paralog of CAPS (Ca2+-dependent activator protein for secretion), and named CAPS2. CAPS2 is enriched on vesicular structures of presynaptic parallel fiber terminals of granule cells connecting postsynaptic spines of Purkinje cell dendrites. Vesicle factions affinity-purified by the CAPS2 antibody from mouse cerebella contained significant amounts of neurotrophin-3 (NT-3), brain-derived neurotrophic factor (BDNF), and chromogranin B but not marker proteins for synaptic vesicle synaptophysin and synaptotagmin. In cerebellar primary cultures, punctate CAPS2 immunoreactivities are primarily colocalized with those of NT-3 and BDNF and near those of a postsynaptic marker, postsynaptic density-95, around dendritic arborization of Purkinje cells. Exogenously expressed CAPS2 enhanced release of exogenous NT-3 and BDNF from PC12 cells and endogenous NT-3 from cultured granule cells in a depolarization-dependent manner. Moreover, the overexpression of CAPS2 in granule cells promotes the survival of Purkinje cells in cerebellar cultures. Thus, we suggest that CAPS2 mediates the depolarization-dependent release of NT-3 and BDNF from granule cells, leading to regulation in cell differentiation and survival during cerebellar development.

20 December 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
Yo ShinodaYo Shinoda
Yo Shinoda
TSTetsushi Sadakata
Tetsushi Sadakata
KNKazuhito Nakao
Kazuhito Nakao
RKRitsuko Katoh-Semba
Ritsuko Katoh-Semba
EKEmi Kinameri
Emi Kinameri
TFTeiichi Furuichi
Teiichi Furuichi
Calcium-dependent activator protein for secretion 2 (CAPS2) is a dense-core vesicle-associated protein that is involved in the secretion of BDNF. BDNF has a pivotal role in neuronal survival and development, including the development of inhibitory neurons and their circuits. However, how CAPS2 affects BDNF secretion and its biological significance in inhibitory neurons are largely unknown. Here we reveal the role of CAPS2 in the regulated secretion of BDNF and show the effect of CAPS2 on the development of hippocampal GABAergic systems. We show that CAPS2 is colocalized with BDNF, both synaptically and extrasynaptically in axons of hippocampal neurons. Overexpression of exogenous CAPS2 in hippocampal neurons of CAPS2-KO mice enhanced depolarization-induced BDNF exocytosis events in terms of kinetics, frequency, and amplitude. We also show that in the CAPS2-KO hippocampus, BDNF secretion is reduced, and GABAergic systems are impaired, including a decreased number of GABAergic neurons and their synapses, a decreased number of synaptic vesicles in inhibitory synapses, and a reduced frequency and amplitude of miniature inhibitory postsynaptic currents. Conversely, excitatory neurons in the CAPS2-KO hippocampus were largely unaffected with respect to field excitatory postsynaptic potentials, miniature excitatory postsynaptic currents, and synapse number and morphology. Moreover, CAPS2-KO mice exhibited several GABA system-associated deficits, including reduced late-phase long-term potentiation at CA3–CA1 synapses, decreased hippocampal theta oscillation frequency, and increased anxiety-like behavior. Collectively, these results suggest that CAPS2 promotes activity-dependent BDNF secretion during the postnatal period that is critical for the development of hippocampal GABAergic networks.

1 October 2008 in Neural Networks
Verified
Journal Article
Closed access
ASAkira Sato
Akira Sato
YSYukiko Sekine
Yukiko Sekine
CSChihiro Saruta
Chihiro Saruta
HNHirozumi Nishibe
Hirozumi Nishibe
NMNoriyuki Morita
Noriyuki Morita
TFTeiichi Furuichi
Teiichi Furuichi

3 December 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
TSTetsushi Sadakata
Tetsushi Sadakata
Yo ShinodaYo Shinoda
Yo Shinoda
MOMegumi Oka
Megumi Oka
YSYukiko Sekine
Yukiko Sekine
YSYumi Sato
Yumi Sato
TFTeiichi Furuichi
Teiichi Furuichi
Ca 2 + -dependent activator protein for secretion 2 (CAPS2 or CADPS2) potently promotes the release of brain-derived neurotrophic factor (BDNF). A rare splicing form of CAPS2 with deletion of exon3 (dex3) was identified to be overrepresented in some patients with autism. Here, we generated Caps2 -dex3 mice and verified a severe impairment in axonal Caps2-dex3 localization, contributing to a reduction in BDNF release from axons. In addition, circuit connectivity, measured by spine and interneuron density, was diminished globally. The collective effect of reduced axonal BDNF release during development was a striking and selective repertoire of deficits in social- and anxiety-related behaviors. Together, these findings represent a unique mouse model of a molecular mechanism linking BDNF-mediated coordination of brain development to autism-related behaviors and patient genotype.